US 12404497
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
granted A61KA61K35/766A61K38/2013
Quick answer
US patent 12404497 (Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof) held by Medicenna Therapeutics Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medicenna Therapeutics Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K35/766, A61K38/2013, A61P, A61P35/00